Cargando…

NBAT1/CASC15-003/USP36 control MYCN expression and its downstream pathway genes in neuroblastoma

BACKGROUND: MYCN has been an attractive therapeutic target in neuroblastoma considering the widespread amplification of the MYCN locus in neuroblastoma, and its established role in neuroblastoma development and progression. Thus, understanding neuroblastoma-specific control of MYCN expression at the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Juvvuna, Prasanna Kumar, Mondal, Tanmoy, Di Marco, Mirco, Kosalai, Subazini Thankaswamy, Kanduri, Meena, Kanduri, Chandrasekhar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Basic and Translational Investigations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156975/ https://www.ncbi.nlm.nih.gov/pubmed/34056606 http://dx.doi.org/10.1093/noajnl/vdab056

Ejemplares similares

Fighting Neuroblastomas with NBAT1
por: Pandey, Gaurav Kumar, et al.
Publicado: (2015)

Global DNA methylation profiling reveals new insights into epigenetically deregulated protein coding and long noncoding RNAs in CLL
por: Subhash, Santhilal, et al.
Publicado: (2016)

EZH2 upregulates the PI3K/AKT pathway through IGF1R and MYC in clinically aggressive chronic lymphocytic leukaemia
por: Kosalai, Subazini Thankaswamy, et al.
Publicado: (2019)

PAN-cancer analysis of S-phase enriched lncRNAs identifies oncogenic drivers and biomarkers
por: Ali, Mohamad Moustafa, et al.
Publicado: (2018)

The DNA damage inducible lncRNA SCAT7 regulates genomic integrity and topoisomerase 1 turnover in lung adenocarcinoma
por: Statello, Luisa, et al.
Publicado: (2021)

HnRNPK maintains single strand RNA through controlling double-strand RNA in mammalian cells
por: Mahale, Sagar, et al.
Publicado: (2022)

Filamin A increases aggressiveness of human neuroblastoma
por: Bandaru, Sashidar, et al.
Publicado: (2022)

Characterization of Lovastatin biosynthetic cluster proteins in Aspergillus terreus strain ATCC 20542
por: Subazini, Thankaswamy Kosalai, et al.
Publicado: (2011)

H3K4me2 and WDR5 enriched chromatin interacting long non-coding RNAs maintain transcriptionally competent chromatin at divergent transcriptional units
por: Subhash, Santhilal, et al.
Publicado: (2018)

Long noncoding RNAs and neuroblastoma
por: Pandey, Gaurav Kumar, et al.
Publicado: (2015)

Sperm Originated Chromatin Imprints and LincRNAs in Organismal Development and Cancer
por: Subhash, Santhilal, et al.
Publicado: (2020)

An ALYREF-MYCN coactivator complex drives neuroblastoma tumorigenesis through effects on USP3 and MYCN stability
por: Nagy, Zsuzsanna, et al.
Publicado: (2021)

CanGeneBase (CGB) ‐ a database on cancer related genes
por: Kumar, Gopal Ramesh, et al.
Publicado: (2009)

BioMet Toolbox 2.0: genome-wide analysis of metabolism and omics data
por: Garcia-Albornoz, Manuel, et al.
Publicado: (2014)

Gene-body hypermethylation controlled cryptic promoter and miR26A1-dependent EZH2 regulation of TET1 gene activity in chronic lymphocytic leukemia
por: Kopparapu, Pradeep Kumar, et al.
Publicado: (2017)

The deubiquitinase USP28 maintains the expression of the transcription factor MYCN and is essential in neuroblastoma cells
por: Li, Junjun, et al.
Publicado: (2023)

MYCN Function in Neuroblastoma Development
por: Otte, Jörg, et al.
Publicado: (2021)

MYCN and Metabolic Reprogramming in Neuroblastoma
por: Bansal, Mohit, et al.
Publicado: (2022)

Metastasis in neuroblastoma: the MYCN question
por: Bhavsar, Swapnil Parashram
Publicado: (2023)

Elevated Expression of H19 and Igf2 in the Female Mouse Eye
por: Reinius, Björn, et al.
Publicado: (2013)

GeneSCF: a real-time based functional enrichment tool with support for multiple organisms
por: Subhash, Santhilal, et al.
Publicado: (2016)

Understanding Long Noncoding RNA and Chromatin Interactions: What We Know So Far
por: Mishra, Kankadeb, et al.
Publicado: (2019)

DFMO/eflornithine inhibits migration and invasion downstream of MYCN and involves p27(Kip1) activity in neuroblastoma
por: KOOMOA, DANA-LYNN T., et al.
Publicado: (2013)

Ferroptosis vulnerability in MYCN‐driven neuroblastomas
por: Dasgupta, Shayani, et al.
Publicado: (2022)

MYCN Amplifications and Metabolic Rewiring in Neuroblastoma
por: Pouliou, Marialena, et al.
Publicado: (2023)

Long Non-Coding RNAs: Tools for Understanding and Targeting Cancer Pathways
por: Pandey, Gaurav Kumar, et al.
Publicado: (2022)

Implementation of the plasma MYCN/NAGK ratio to detect MYCN amplification in patients with neuroblastoma
por: Su, Yan, et al.
Publicado: (2020)

MYCN upregulates the transsulfuration pathway to suppress the ferroptotic vulnerability in MYCN-amplified neuroblastoma
por: Floros, Konstantinos V., et al.
Publicado: (2022)

Global distribution of DNA hydroxymethylation and DNA methylation in chronic lymphocytic leukemia
por: Wernig-Zorc, Sara, et al.
Publicado: (2019)

MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma
por: Agarwal, Saurabh, et al.
Publicado: (2018)

Therapeutic potential of targeting MYCN: A case series report of neuroblastoma with MYCN amplification
por: Huang, Can, et al.
Publicado: (2020)

A MYCN-independent mechanism mediating secretome reprogramming and metastasis in MYCN-amplified neuroblastoma
por: Zhang, Hai-Feng, et al.
Publicado: (2023)

Regulation of MYCN expression in human neuroblastoma cells
por: Jacobs, Joannes FM, et al.
Publicado: (2009)

MYCN and mutationally activated ALK synergise in neuroblastoma
Publicado: (2012)

MYCN amplification and ATRX mutations are incompatible in neuroblastoma
por: Zeineldin, Maged, et al.
Publicado: (2020)

MYCN in Neuroblastoma: “Old Wine into New Wineskins”
por: Braoudaki, Maria, et al.
Publicado: (2021)

Targeting MYCN and ALK in resistant and relapsing neuroblastoma
por: Tucker, Elizabeth R, et al.
Publicado: (2019)

The MicroRNA Landscape of MYCN-Amplified Neuroblastoma
por: Misiak, Danny, et al.
Publicado: (2021)

Heterogeneous MYCN amplification in neuroblastoma: a SIOP Europe Neuroblastoma Study
por: Berbegall, Ana P., et al.
Publicado: (2018)

MYCN is amplified during S phase, and c-myb is involved in controlling MYCN expression and amplification in MYCN-amplified neuroblastoma cell lines
por: Aygun, Nevim, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2mdk0ptv7d4f70d89la4um771m